ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

169
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
15 Jan 2019 06:58

2018 HK-Connect SouthBound In a Nutshell

Since autumn of 2014, the HK-Shanghai Connect, and later the HK-Shenzhen Connect mechanisms have provided means for mainland investors to buy Hong...

Logo
700 Views
Share
17 Dec 2018 11:06

Discover HK Connect: Mainlanders Are Buying Shandong Gold, and Pharmaceuticals (2018-12-17)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
456 Views
Share
bearishWuXi AppTec
28 Nov 2018 05:57

WuXi AppTech IPO Update: Figuring Out the Right AH Premium

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
722 Views
Share
21 Oct 2018 08:51

Last Week in Event SPACE: Spring REIT, Alps/Alpine, NTT, JCNC, Restaurant Brands, A/H

Last Week in Event SPACE ... A previously non-disclosed connected party tarnishes a property acquisition and bolsters PAG's Offer for Spring Real...

Logo
494 Views
Share
22 Jul 2018 16:09

Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation

Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...

Logo
755 Views
Share
x